Email this page: News Release

MEDIVATION PRESENTS POSITIVE NEW DATA ON DIMEBON'S LONG-TERM EFFICACY AND NOVEL MECHANISM OF ACTION AT THE INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE

To (email address):   Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:   Copy yourself These email addresses will be used to email the page on your behalf and will not be used by Medivation, Inc. for any marketing purposes.
Add a comment:
Send:    Full page    Link to page
Type in number:
This helps Medivation, Inc. prevent automated submissions.